- Home
- TENX vs AVX Comparison
TENX vs AVX Comparison
Compare TENX & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TENX | AVX |
|---|---|---|
| Founded | 1967 | 2017 |
| Country | United States | Canada |
| Employees | N/A | 7 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.2M | 50.6M |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | TENX | AVX |
|---|---|---|
| Price | $11.75 | $0.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $29.67 | N/A |
| AVG Volume (30 Days) | ★ 605.5K | 590.0K |
| Earning Date | 05-15-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.34 | $0.44 |
| 52 Week High | $18.38 | $2.27 |
Technical Indicators
Market Signals| Indicator | TENX | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 37.17 | 45.04 |
| Support Level | $10.83 | $0.46 |
| Resistance Level | $14.15 | $0.74 |
| Average True Range (ATR) | 0.95 | 0.05 |
| MACD | -0.28 | 0.01 |
| Stochastic Oscillator | 7.00 | 49.97 |
Price Performance
Historical ComparisonAbout TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. It focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.